Drug Delivery Devices - Vietnam

Vietnam

Highlights

In Vietnam, revenue in the Drug Delivery Devices market market is projected to reach US$65.51m in 2024.
It is expected that revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 7.08%, leading to a market volume of US$92.21m by 2029.
In comparison with global figures, the United States will generate the most revenue, amounting to US$15.01bn in 2024.
Vietnam's healthcare sector is increasingly adopting innovative drug delivery devices, driven by rising patient expectations and a growing emphasis on advanced medical technologies.

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Drug Delivery Devices Market in Vietnam is experiencing moderate growth, influenced by factors such as increased healthcare spending, the rising prevalence of chronic diseases, and advancements in technology, which enhance the efficiency of treatment delivery systems.

Customer preferences: In Vietnam, consumers are increasingly prioritizing personalized healthcare solutions, driving demand for advanced drug delivery devices that cater to individual treatment needs. The rising awareness of chronic diseases has led to a preference for devices that offer convenience and ease of use, such as smart inhalers and wearable injectors. Additionally, younger demographics are embracing technology-driven solutions, favoring devices that integrate with mobile applications for better medication adherence and real-time health monitoring, reflecting a cultural shift towards proactive health management.

Trends in the market: In Vietnam, the Drug Delivery Devices market is experiencing a shift towards innovative and user-friendly technologies, driven by a growing emphasis on patient-centered care. There is a notable increase in the adoption of smart inhalers and wearable injectors that enhance medication adherence, particularly among individuals managing chronic conditions. Additionally, the integration of mobile applications with these devices is becoming popular, enabling real-time health tracking and personalized treatment adjustments. This trend signifies a broader commitment to improving health outcomes and may lead to increased collaboration between device manufacturers and healthcare providers to develop tailored solutions that meet the evolving needs of the Vietnamese population.

Local special circumstances: In Vietnam, the Drug Delivery Devices market is shaped by unique local factors such as a rapidly aging population and a high prevalence of chronic diseases. The country's healthcare infrastructure is evolving, with increasing government support for modern medical technologies. Cultural attitudes towards health and wellness encourage a preference for innovative treatments, while urbanization drives demand for portable and discreet drug delivery solutions. Additionally, regulatory frameworks are gradually adapting to facilitate the introduction of advanced devices, fostering collaboration between local manufacturers and global firms to enhance healthcare accessibility and outcomes.

Underlying macroeconomic factors: The Drug Delivery Devices market in Vietnam is significantly influenced by macroeconomic factors such as national economic health, government fiscal policies, and global economic trends. The Vietnamese economy is witnessing steady growth, bolstered by foreign investments and a burgeoning middle class, which enhances demand for advanced medical technologies. Supportive fiscal policies aimed at healthcare modernization encourage innovation and accessibility in drug delivery solutions. Additionally, rising healthcare expenditures, coupled with a focus on managing chronic diseases, drive market expansion. Global trends in medical technology adoption further support the integration of sophisticated drug delivery devices, enhancing patient outcomes and aligning with local healthcare needs.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.